These 2 ‘Strong Buy' Penny Stocks Could Rally Over 500%, Say Analysts [Yahoo! Finance]
Regulus Therapeutics Inc. (RGLS)
Last regulus therapeutics inc. earnings: 3/12 04:37 pm
Check Earnings Report
US:NASDAQ Investor Relations:
regulusrx.com/investors
Company Research
Source: Yahoo! Finance
for investors: no matter the strategy, success in the stock market ultimately depends on how well you navigate the balance between risk and reward. Few corners of the stock market present a greater potential return for the risk than penny stocks, which trade at $5 or less. These ultra-low-priced equities offer an attractive entry point for investors looking to seize high-risk, high-reward opportunities. The low entry cost of penny stocks offers the potential for substantial gains, as even a small increase in share price can lead to impressive percentage returns. It's not uncommon for penny stocks to have upside potentials of 300%, 400%, or more. However, the other side of the coin is just as important – with high reward comes heightened risk. The key here is to find the difference between penny stocks priced low due to weak fundamentals, and those that are undervalued, with real potential to soar. To help with the due diligence process, we used the TipRanks database to zero in
Show less
Read more
Impact Snapshot
Event Time:
RGLS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGLS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGLS alerts
High impacting Regulus Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
RGLS
News
- Polycystic Kidney Diseases Therapeutics Market Report 2024: Comprehensive Insights About 8+ Companies and 10+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
- Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences [Yahoo! Finance]Yahoo! Finance
- Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment ConferencesPR Newswire
- Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.MarketBeat
- Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent UpdatesPR Newswire
RGLS
Earnings
- 8/8/24 - In-Line
RGLS
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- RGLS's page on the SEC website